Barclays Raises Estimates on SLM Corp. (SLM); Buyback Announcement A Surprise Catalyst
Tweet Send to a FriendGet Alerts SLM Hot Sheet
Price: $22.84 +0.44%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 33 | New: 12
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 33 | New: 12
Trade SLM Now!
Barclays reiterates an 'Overweight' on SLM Corp. (NASDAQ: SLM) price target of $18.00.
Analyst, Mark C. DeVries, said, "SLM announced a $400mm addition to the existing repurchase authorization after the close Tuesday that we believe was generally unexpected by the market...after adding another $400mm of buybacks (roughly 27mm shares), we are raising our estimates for 2012 and 2013 to $2.19 and $2.28, from $2.17 and $2.24, respectively."
For an analyst ratings summary and ratings history on SLM Corp. click here. For more ratings news on SLM Corp. click here.
Shares of SLM Corp. closed at $13.80 yesterday, with a 52 week range of $10.91-$17.11.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Mark C. DeVries, said, "SLM announced a $400mm addition to the existing repurchase authorization after the close Tuesday that we believe was generally unexpected by the market...after adding another $400mm of buybacks (roughly 27mm shares), we are raising our estimates for 2012 and 2013 to $2.19 and $2.28, from $2.17 and $2.24, respectively."
For an analyst ratings summary and ratings history on SLM Corp. click here. For more ratings news on SLM Corp. click here.
Shares of SLM Corp. closed at $13.80 yesterday, with a 52 week range of $10.91-$17.11.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
- Goldman Sachs Upgrades WNS (Holdings) (WNS) to Buy
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Stock BuybacksRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
